Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
Chronic kidney disease (CKD) is the most common cause of end-stage renal disease in patients with type 2 diabetes mellitus (T2DM). CKD increases the risk of cardiovascular diseases; therefore, its prevention and treatment are important. The prevention of diabetic kidney disease (DKD) can be achieved...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Korean Endocrine Society
2023-02-01
|
| Seri Bilgileri: | Endocrinology and Metabolism |
| Konular: | |
| Online Erişim: | http://www.e-enm.org/upload/pdf/enm-2022-1629.pdf |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|